| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.83B | 55.39B | 50.63B | 48.81B | 45.12B | 40.86B |
| Gross Profit | 23.20B | 24.72B | 22.48B | 20.92B | 18.16B | 17.38B |
| EBITDA | 6.00B | 6.53B | 5.65B | 5.40B | 4.22B | 3.88B |
| Net Income | 2.50B | 3.31B | 2.37B | 2.00B | 1.76B | 1.47B |
Balance Sheet | ||||||
| Total Assets | 65.69B | 76.77B | 68.63B | 64.73B | 63.91B | 60.69B |
| Cash, Cash Equivalents and Short-Term Investments | 17.61B | 27.39B | 19.16B | 16.43B | 16.94B | 17.91B |
| Total Debt | 4.13B | 1.37B | 3.50B | 3.02B | 3.84B | 2.91B |
| Total Liabilities | 15.00B | 15.20B | 16.04B | 15.49B | 15.14B | 13.75B |
| Stockholders Equity | 47.74B | 58.32B | 49.51B | 46.58B | 46.24B | 44.72B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.40B | 5.01B | 4.16B | -819.00M | 867.00M |
| Operating Cash Flow | 0.00 | 5.88B | 5.62B | 5.07B | 583.00M | 1.63B |
| Investing Cash Flow | 0.00 | 1.06B | -2.40B | -928.00M | -2.79B | -752.00M |
| Financing Cash Flow | 0.00 | 2.76B | -2.08B | -5.23B | -1.44B | -458.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥106.76B | 19.73 | ― | 0.82% | 8.60% | 28.39% | |
82 Outperform | ¥171.32B | 16.73 | ― | 1.39% | 12.59% | 26.31% | |
75 Outperform | ¥297.30B | 21.26 | ― | 2.42% | 4.46% | 23.01% | |
72 Outperform | ¥13.80B | 12.63 | ― | 3.98% | 4.54% | -17.09% | |
70 Outperform | ¥53.85B | 14.18 | ― | 3.69% | 9.40% | 34.69% | |
64 Neutral | ¥2.82T | 22.84 | 8.35% | 1.77% | 4.75% | 6.22% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |